Revvity (MEX:PKI) Cyclically Adjusted Revenue per Share: MXN560.42 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:PKI Revvity Inc MEX:PKI
75 GF Score
Price MXN1,644.85
GF Value MXN1,782.70
! 11 Warning Signs
View Full Analysis

What is Revvity Cyclically Adjusted Revenue per Share?

Revvity MEX:PKI 75 Cyclically Adjusted Revenue per Share is MXN560.42 as of Mar. 2026. GuruFocus rates MEX:PKI with a GF Score™ of 75/100 and a GF Value™ of MXN1,782.70. The stock has 11 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Revvity's adjusted revenue per share for the three months ended in Mar. 2026 was MXN114.621. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN560.42 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Revvity's average Cyclically Adjusted Revenue Growth Rate was 3.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Revvity was 9.00% per year. The lowest was -8.20% per year. And the median was 2.10% per year.

As of today (2026-07-15), Revvity's current stock price is MXN1644.85. Revvity's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was MXN560.42. Revvity's Cyclically Adjusted PS Ratio of today is 2.94.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Revvity was 7.91. The lowest was 2.77. And the median was 4.16.


Revvity  (MEX:PKI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Revvity's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1644.85/560.42
=2.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Revvity was 7.91. The lowest was 2.77. And the median was 4.16.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Revvity Cyclically Adjusted Revenue per Share Related Terms


Revvity Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Revvity's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revvity Cyclically Adjusted Revenue per Share Chart

Revvity Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 487.45 576.13 618.78 619.91 528.61

Revvity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 660.81 727.60 553.96 528.61 560.42

MEX:PKI vs ICLR, CRL, MEDP: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Revvity's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revvity Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Revvity's Cyclically Adjusted PS Ratio falls into.


MEX:PKI
75GF Score
Revvity Inc MEX:PKI
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revvity Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Revvity's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=114.621/330.2130*330.2130
=114.621

Current CPI (Mar. 2026) = 330.2130.

Revvity Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 90.283 241.018 123.695
201609 90.371 241.428 123.605
201612 106.097 241.432 145.112
201703 87.840 243.801 118.974
201706 89.262 244.955 120.330
201709 90.627 246.819 121.248
201712 113.039 246.524 151.413
201803 105.088 249.554 139.054
201806 124.006 251.989 162.501
201809 112.871 252.439 147.645
201812 133.066 251.233 174.898
201903 113.073 254.202 146.884
201906 124.442 256.143 160.427
201909 125.100 256.759 160.889
201912 136.097 256.974 174.885
202003 137.019 258.115 175.292
202006 167.483 257.797 214.530
202009 189.651 260.280 240.607
202012 41.555 260.474 52.681
202103 237.615 264.877 296.226
202106 217.529 271.696 264.380
202109 153.974 274.310 185.353
202112 166.330 278.802 197.001
202203 151.439 287.504 173.935
202206 142.429 296.311 158.725
202209 113.149 296.808 125.884
202212 114.504 296.797 127.396
202303 96.185 301.836 105.228
202306 96.941 305.109 104.917
202309 94.068 307.789 100.921
202312 95.776 306.746 103.103
202403 87.311 312.332 92.310
202406 102.624 314.175 107.863
202409 109.482 315.301 114.660
202412 125.270 315.605 131.068
202503 113.112 319.799 116.795
202506 115.387 322.561 118.124
202509 111.046 324.800 112.897
202512 122.831 324.054 125.166
202603 114.621 330.213 114.621

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN560.42 mean?
Revvity (MEX:PKI) has a Cyclically Adjusted Revenue per Share of MXN560.42 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Revvity and its competitors.
Is Revvity's Cyclically Adjusted Revenue per Share too high?
Revvity's current Cyclically Adjusted Revenue per Share is MXN560.42. Overall, Revvity has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Revvity's Cyclically Adjusted Revenue per Share compare to ICLR and CRL?
Revvity's Cyclically Adjusted Revenue per Share of MXN560.42 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Revvity and its competitors. Revvity's current Cyclically Adjusted Revenue per Share is MXN560.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revvity stock overvalued right now?
Revvity (MEX:PKI) has a current Cyclically Adjusted Revenue per Share of MXN560.42. The stock's GF Value™ is MXN1,782.70, compared to a current price of MXN1,644.85 — trading 7.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN560.42. Revvity's overall GF Score™ is 75/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Revvity (MEX:PKI), the current Cyclically Adjusted Revenue per Share is MXN560.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revvity (MEX:PKI) Overvalued in 2026?

Based on GuruFocus' analysis, Revvity stock appears to be undervalued. The current stock price of MXN1,644.85 is trading 7.7% below its estimated GF Value™ of MXN1,782.70.

Key valuation signals for MEX:PKI:

  • Cyclically Adjusted Revenue per Share: MXN560.42
  • GF Value™: MXN1,782.70 vs. price of MXN1,644.85 (7.7% below fair value)
  • GF Score™: 75/100 with 11 warning signs

No single metric tells the full story. See the MEX:PKI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Revvity Business Description

Address 77 4th Avenue, Waltham, MA, USA, 02451
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
75GF Score

Get the complete analysis for MEX:PKI

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,644.85
Price
MXN1,782.70
GF Value